日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Author Correction: Autologous T cell therapy for PRAME(+) advanced solid tumors in HLA-A*02(+) patients: a phase 1 trial

作者更正:自体T细胞疗法治疗HLA-A*02(+)患者的PRAME(+)晚期实体瘤:一项I期试验

Wermke, Martin; Araujo, Dejka M; Chatterjee, Manik; Tsimberidou, Apostolia M; Holderried, Tobias A W; Jazaeri, Amir A; Reshef, Ran; Bokemeyer, Carsten; Alsdorf, Winfried; Wetzko, Katrin; Brossart, Peter; Aslan, Katrin; Backert, Linus; Bunk, Sebastian; Fritsche, Jens; Gulde, Swapna; Hengler, Silvana; Hilf, Norbert; Hossain, Mohammad B; Hukelmann, Jens; Kalra, Mamta; Krishna, Delfi; Kursunel, M Alper; Maurer, Dominik; Mayer-Mokler, Andrea; Mendrzyk, Regina; Mohamed, Ali; Pozo, Karine; Satelli, Arun; Letizia, Marilena; Schuster, Heiko; Schoor, Oliver; Wagner, Claudia; Rammensee, Hans-Georg; Reinhardt, Carsten; Singh-Jasuja, Harpreet; Walter, Steffen; Weinschenk, Toni; Luke, Jason J; Britten, Cedrik M

Autologous T cell therapy for PRAME(+) advanced solid tumors in HLA-A*02(+) patients: a phase 1 trial

自体T细胞疗法治疗HLA-A*02(+)患者的PRAME(+)晚期实体瘤:一项I期试验

Wermke, Martin; Araujo, Dejka M; Chatterjee, Manik; Tsimberidou, Apostolia M; Holderried, Tobias A W; Jazaeri, Amir A; Reshef, Ran; Bokemeyer, Carsten; Alsdorf, Winfried; Wetzko, Katrin; Brossart, Peter; Aslan, Katrin; Backert, Linus; Bunk, Sebastian; Fritsche, Jens; Gulde, Swapna; Hengler, Silvana; Hilf, Norbert; Hossain, Mohammad B; Hukelmann, Jens; Kalra, Mamta; Krishna, Delfi; Kursunel, M Alper; Maurer, Dominik; Mayer-Mokler, Andrea; Mendrzyk, Regina; Mohamed, Ali; Pozo, Karine; Satelli, Arun; Letizia, Marilena; Schuster, Heiko; Schoor, Oliver; Wagner, Claudia; Rammensee, Hans-Georg; Reinhardt, Carsten; Singh-Jasuja, Harpreet; Walter, Steffen; Weinschenk, Toni; Luke, Jason J; Britten, Cedrik M

Phase I Dose-Escalation Results for the Delta-Like Ligand 3/CD3 IgG-Like T-Cell Engager Obrixtamig (BI 764532) in Patients With Delta-Like Ligand 3+ Small Cell Lung Cancer or Neuroendocrine Carcinomas

Delta样配体3/CD3 IgG样T细胞衔接剂Obrixtamig(BI 764532)在Delta样配体3+小细胞肺癌或神经内分泌癌患者中的I期剂量递增结果

Wermke, Martin; Gambardella, Valentina; Kuboki, Yasutoshi; Felip, Enriqueta; Sanmamed, Miguel F; Alese, Olatunji B; Sayehli, Cyrus M; Arriola, Edurne; Wolf, Jürgen; Villaruz, Liza C; Bertulis, Julia; Studeny, Matus; Bouzaggou, Mohamed; Fang, Xiaoyan; Morgensztern, Daniel

Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study

Lifileucel肿瘤浸润淋巴细胞疗法治疗晚期黑色素瘤患者的长期疗效和安全性:C-144-01研究的5年分析

Medina, Theresa; Chesney, Jason A; Kluger, Harriet M; Hamid, Omid; Whitman, Eric D; Cusnir, Mike; Thomas, Sajeve S; Wermke, Martin; Domingo-Musibay, Evidio; Phan, Giao Q; Kirkwood, John M; Larkin, James; Weber, Jeffrey; Graf Finckenstein, Friedrich; Chou, Jeffrey; Gastman, Brian; Wu, Xiao; Fiaz, Rana; Sarnaik, Amod A

Histologic Transformation in Cancer: The Path for Clinical Translation

癌症的组织学转化:通往临床转化的路径

Vathiotis, Ioannis; Banerjee, Avisek; Sen, Utsav; Saalfeld, Felix C; Halder, Debdatta; Charpidou, Andriani; Syrigos, Konstantinos N; Horinouchi, Hidehito; Tewari, Ashutosh K; Dawson, Mark A; Wermke, Martin; Sen, Triparna

Oligometastatic non-small cell lung cancer: Impact of local and contemporary systemic treatment approaches on clinical outcome

寡转移性非小细胞肺癌:局部和现代全身治疗方法对临床结果的影响

Wiesweg, Marcel; Küter, Claudia; Schnorbach, Johannes; Keyl, Julius; Metzenmacher, Martin; Cvetkovic, Jelena; Saalfeld, Felix Carl; Glanemann, Franziska; Eberhardt, Wilfried; Oezkan, Filiz; Theegarten, Dirk; Stenzinger, Albrecht; Darwiche, Kaid; Koschel, Dirk; Herth, Felix; Bölükbas, Servet; Winter, Hauke; Weykamp, Fabian; Wermke, Martin; Stuschke, Martin; Plönes, Till; Thomas, Michael; Schuler, Martin; Christopoulos, Petros

First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms

MDG1011(一种针对HLA-A*02:01限制性PRAME抗原的TCR-T疗法)在人体中的首次研究,用于治疗高危髓系和淋巴系肿瘤

Thomas, Simone; Wermke, Martin; Vučinić, Vladan; Wagner-Drouet, Eva; Mackensen, Andreas; Zeiser, Robert; Bug, Gesine; Schmitt, Michael; Herr, Wolfgang; Prinz, Petra U; Bürdek, Maja; Raffegerst, Silke; Tafuri, Anna; Geiger, Christiane; Crame, Kirsty; Goedkoop, René; Pinkernell, Kai; Schendel, Dolores J

Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415)

重新考虑在非小细胞肺癌中使用姑息性放射疗法联合 PD-1 阻断疗法:FORCE II 期试验结果 (AIO/YMO-TRK-0415)

Bozorgmehr, Farastuk; Chung, Inn; Fischer, Jürgen R; Bischof, Marc; Atmaca, Akin; Wetzel, Sophie; Faehling, Martin; Bottke, Dirk; Wermke, Martin; Troost, Esther G C; Kropf-Sanchen, Cornelia; Wiegel, Thomas; Schmidt, Bernd; Stupavsky, Andrej; Engel-Riedel, Walburga; Hammer-Hellmig, Michaela; Reinmuth, Niels; Manapov, Farkhad; Grohe, Christian; Krempien, Robert; Schumann, Christian; Sterzing, Florian; Reck, Martin; Würschmidt, Florian; Fleckenstein, Jochen; Petroff, Alev; Henschke, Sven; Behnisch, Rouven; Cvetkovic, Jelena; Brückner, Lena; Schwab, Constantin; Stenzinger, Albrecht; Götze, Thorsten; Kopp, Christina; Schröder, Helge; Debus, Jürgen; Christopoulos, Petros; Thomas, Michael; Rieken, Stefan

Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany: a historical cohort analysis

德国一项针对晚期非小细胞肺癌患者的全国性精准医疗项目有效性评估:一项历史性队列分析

Kästner, Anika; Kron, Anna; van den Berg, Neeltje; Moon, Kilson; Scheffler, Matthias; Schillinger, Gerhard; Pelusi, Natalie; Hartmann, Nils; Rieke, Damian Tobias; Stephan-Falkenau, Susann; Schuler, Martin; Wermke, Martin; Weichert, Wilko; Klauschen, Frederick; Haller, Florian; Hummel, Horst-Dieter; Sebastian, Martin; Gattenlöhner, Stefan; Bokemeyer, Carsten; Esposito, Irene; Jakobs, Florian; von Kalle, Christof; Büttner, Reinhard; Wolf, Jürgen; Hoffmann, Wolfgang

First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors

首次人体剂量递增试验,旨在评估抗MAGEA1自体TCR转基因T细胞疗法在复发和难治性实体瘤中的临床安全性和有效性

Wermke, Martin; Holderried, Tobias A W; Luke, Jason John; Morris, Van K; Alsdorf, Winfried H; Wetzko, Katrin; Andersson, Borje S; Wistuba, Ignacio I; Parra, Edwin R; Hossain, Mohammad B; Grund-Gröschke, Sandra; Aslan, Katrin; Satelli, Arun; Marisetty, Anantha; Satam, Swapna; Kalra, Mamta; Hukelmann, Jens; Kursunel, M Alper; Pozo, Karine; Acs, Andreas; Backert, Linus; Baumeister, Melissa; Bunk, Sebastian; Wagner, Claudia; Schoor, Oliver; Mohamed, Ali S; Mayer-Mokler, Andrea; Hilf, Norbert; Krishna, Delfi; Walter, Steffen; Tsimberidou, Apostolia M; Britten, Cedrik M